Pujalte 1994.

Methods	Allocation: "random allocation" ‐ no further details. Blindness: double ‐ placebo identical appearance to clonazepam solution. Duration: 2 weeks.
Participants	Diagnosis: schizophrenia and schizoaffective disorders (DSM‐III‐R) plus neuroleptic‐induced akathisa (Barnes Rating Scale for Drug‐Induced Akathisia). N=12. Age: mean ˜34 years. Sex: female 4, male 8. History: "acutely ill", duration of illness not specified.
Interventions	1. Clonazepam: dose 0.5‐2.5mg/day. N=6. 2. Placebo. N=6.
Outcomes	Akathisia: Barnes Rating Scale for Drug‐Induced Akathisia, use of antiparkinsonian medicaton. Adverse effects. Unable to use ‐ Akathisia: Barnes Rating Scale for Drug‐Induced Akathisia score (inexact p‐value).
Notes	Authors contacted for details on 17th March 2000.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear

EPRS ‐ Extra‐pyramidal symptom rating scale.